CME Group Inc.
CME Group Inc. Announces Amendments to Stock Plan
Summary
On March 4, 2024, CME Group Inc.'s Compensation Committee approved an amended Omnibus Stock Plan effective as of March 1, 2024. The amendments introduce double trigger change of control vesting provisions to better align with market practices and shareholder preferences. Under the new terms, equity awards granted after March 1, 2024, will accelerate vesting in the event of a Change of Control under specific conditions. The Amended Omnibus Stock Plan replaces the previous version, which was attached to the Company's Annual Report on Form 10-K filed on February 28, 2024.
Profitelligence Alerts
Get alerts for CME
Be first to know when CME Group Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About CME Group Inc.
CME Group Inc. is a leading global marketplace for derivatives and futures trading. It provides a diverse range of products, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. CME Group's primary function is to facilitate risk management and price discovery, offering a centralized marketplace where traders can hedge against fluctuations in these various markets. Notable features include its electronic trading platform, CME Globex, enabling seamless access to its services worldwide, and its clearing services, ensuring the integrity and stability of the financial system. CME Group is crucial for market participants who require precise risk management tools, boasting significant influence in sectors like agriculture, energy, and global finance. As one of the largest futures and options exchanges, CME Group plays a pivotal role in the financial market by providing liquidity, transparency, and efficiency in trading activities.
Official SEC Documents
Advertisement